Families await dupilumab access as PBAC reviews pediatric subsidy request
Eight-year-old Aaron Cookson lost three fingertips due to severe eczema, which left him hospitalized multiple times. His family could not access dupilumab, a treatment available for older children since 2021, despite recommendations for younger patients. As the PBAC reviews a proposal for subsidizing this medication for those six months to 12 years, families await much-needed relief.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 06 Jul 2026, 09:30 UTC · Updated 06 Jul 2026, 09:40 UTC
Summary by OZbrief Editorial. Original report: SMH. Editorial policy · Corrections
Trending
- Breaking: Senior WA minister Paul Papalia set to resign, triggering by-election
- Fogarty kicks four as Crows bounce back to beat Eagles
- Germany mandates doctor's note on first day of illness for workers
- ‘Barely coherent noise’: Albanese blasts budget critics and the ‘axis of grievance’
- NAIDOC Week kicks off 50th anniversary celebrating the meaning of 'deadly
- Michael Matthews prepares for Tour de France after serious training crash